QIAGEN N.V. (QGEN) Stock Fundamental Analysis
NYSE:QGEN - NL0015002CX3 - Common Stock
46.5 USD
+0.36 (+0.78%)
47.1 USD
+0.6 (+1.29%)
Overall QGEN gets a fundamental rating of 6 out of 10. We evaluated QGEN against 54 industry peers in the Life Sciences Tools & Services industry. While QGEN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. QGEN is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
QGEN had positive earnings in the past year.
QGEN had a positive operating cash flow in the past year.
Each year in the past 5 years QGEN has been profitable.
In the past 5 years QGEN always reported a positive cash flow from operatings.
1.2 Ratios
Looking at the Return On Assets, with a value of 6.41%, QGEN belongs to the top of the industry, outperforming 81.48% of the companies in the same industry.
QGEN has a better Return On Equity (10.65%) than 79.63% of its industry peers.
Looking at the Return On Invested Capital, with a value of 8.51%, QGEN belongs to the top of the industry, outperforming 83.33% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for QGEN is significantly below the industry average of 16.00%.
The last Return On Invested Capital (8.51%) for QGEN is above the 3 year average (7.25%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.41% | ||
| ROE | 10.65% | ||
| ROIC | 8.51% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
1.3 Margins
The Profit Margin of QGEN (18.30%) is better than 90.74% of its industry peers.
In the last couple of years the Profit Margin of QGEN has declined.
The Operating Margin of QGEN (26.40%) is better than 94.44% of its industry peers.
In the last couple of years the Operating Margin of QGEN has grown nicely.
QGEN has a better Gross Margin (63.73%) than 87.04% of its industry peers.
QGEN's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.4% | ||
| PM (TTM) | 18.3% | ||
| GM | 63.73% |
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), QGEN is creating some value.
The number of shares outstanding for QGEN has been reduced compared to 1 year ago.
The number of shares outstanding for QGEN has been reduced compared to 5 years ago.
QGEN has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.99 indicates that QGEN is not in any danger for bankruptcy at the moment.
QGEN's Altman-Z score of 3.99 is fine compared to the rest of the industry. QGEN outperforms 77.78% of its industry peers.
QGEN has a debt to FCF ratio of 2.91. This is a good value and a sign of high solvency as QGEN would need 2.91 years to pay back of all of its debts.
QGEN has a Debt to FCF ratio of 2.91. This is in the better half of the industry: QGEN outperforms 79.63% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that QGEN is not too dependend on debt financing.
The Debt to Equity ratio of QGEN (0.25) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 2.91 | ||
| Altman-Z | 3.99 |
ROIC/WACC1.16
WACC7.36%
2.3 Liquidity
A Current Ratio of 1.61 indicates that QGEN should not have too much problems paying its short term obligations.
The Current ratio of QGEN (1.61) is worse than 68.52% of its industry peers.
QGEN has a Quick Ratio of 1.35. This is a normal value and indicates that QGEN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of QGEN (1.35) is worse than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.35 |
3. Growth
3.1 Past
QGEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.05%, which is quite good.
Measured over the past years, QGEN shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.25% on average per year.
The Revenue has been growing slightly by 5.15% in the past year.
Measured over the past years, QGEN shows a small growth in Revenue. The Revenue has been growing by 5.32% on average per year.
EPS 1Y (TTM)13.05%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%9.09%
Revenue 1Y (TTM)5.15%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%7.49%
3.2 Future
Based on estimates for the next years, QGEN will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.18% on average per year.
QGEN is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.38% yearly.
EPS Next Y8.65%
EPS Next 2Y8.48%
EPS Next 3Y8.94%
EPS Next 5Y8.18%
Revenue Next Year5.1%
Revenue Next 2Y5.38%
Revenue Next 3Y5.89%
Revenue Next 5Y7.38%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 19.79, which indicates a rather expensive current valuation of QGEN.
Based on the Price/Earnings ratio, QGEN is valued cheaper than 83.33% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.17. QGEN is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 17.91, QGEN is valued on the expensive side.
QGEN's Price/Forward Earnings ratio is rather cheap when compared to the industry. QGEN is cheaper than 85.19% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of QGEN to the average of the S&P500 Index (22.78), we can say QGEN is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.79 | ||
| Fwd PE | 17.91 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, QGEN is valued cheaply inside the industry as 83.33% of the companies are valued more expensively.
QGEN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. QGEN is cheaper than 85.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.3 | ||
| EV/EBITDA | 14.1 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
QGEN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.29
PEG (5Y)2.4
EPS Next 2Y8.48%
EPS Next 3Y8.94%
5. Dividend
5.1 Amount
With a yearly dividend of 0.51%, QGEN is not a good candidate for dividend investing.
QGEN's Dividend Yield is rather good when compared to the industry average which is at 0.54. QGEN pays more dividend than 90.74% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, QGEN's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.51% |
5.2 History
QGEN is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DPN/A
EPS Next 2Y8.48%
EPS Next 3Y8.94%
46.5
+0.36 (+0.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners87.24%
Inst Owner Change-22.15%
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap10.07B
Analysts76.67
Price Target52.71 (13.35%)
Short Float %3.1%
Short Ratio4.53
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.51% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.7%
Min EPS beat(2)-2.4%
Max EPS beat(2)7.8%
EPS beat(4)2
Avg EPS beat(4)1.23%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.14%
EPS beat(12)8
Avg EPS beat(12)3.44%
EPS beat(16)12
Avg EPS beat(16)5.26%
Revenue beat(2)1
Avg Revenue beat(2)0.66%
Min Revenue beat(2)-0.12%
Max Revenue beat(2)1.43%
Revenue beat(4)1
Avg Revenue beat(4)-0.16%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.61%
Revenue beat(12)3
Avg Revenue beat(12)-0.41%
Revenue beat(16)7
Avg Revenue beat(16)0.85%
PT rev (1m)2.26%
PT rev (3m)5.11%
EPS NQ rev (1m)0.19%
EPS NQ rev (3m)-0.22%
EPS NY rev (1m)0.08%
EPS NY rev (3m)0.53%
Revenue NQ rev (1m)1.72%
Revenue NQ rev (3m)2.28%
Revenue NY rev (1m)0.81%
Revenue NY rev (3m)1.05%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.79 | ||
| Fwd PE | 17.91 | ||
| P/S | 4.94 | ||
| P/FCF | 20.3 | ||
| P/OCF | 14.92 | ||
| P/B | 2.87 | ||
| P/tB | 15.75 | ||
| EV/EBITDA | 14.1 |
EPS(TTM)2.35
EY5.05%
EPS(NY)2.6
Fwd EY5.58%
FCF(TTM)2.29
FCFY4.93%
OCF(TTM)3.12
OCFY6.7%
SpS9.42
BVpS16.19
TBVpS2.95
PEG (NY)2.29
PEG (5Y)2.4
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.41% | ||
| ROE | 10.65% | ||
| ROCE | 11.47% | ||
| ROIC | 8.51% | ||
| ROICexc | 10.68% | ||
| ROICexgc | 45.66% | ||
| OM | 26.4% | ||
| PM (TTM) | 18.3% | ||
| GM | 63.73% | ||
| FCFM | 24.31% |
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexcg growth 3Y-31.24%
ROICexcg growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 2.91 | ||
| Debt/EBITDA | 1.22 | ||
| Cap/Depr | 94.78% | ||
| Cap/Sales | 8.78% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 92.78% | ||
| Profit Quality | 132.83% | ||
| Current Ratio | 1.61 | ||
| Quick Ratio | 1.35 | ||
| Altman-Z | 3.99 |
F-Score8
WACC7.36%
ROIC/WACC1.16
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)13.05%
EPS 3Y-6.88%
EPS 5Y8.25%
EPS Q2Q%9.09%
EPS Next Y8.65%
EPS Next 2Y8.48%
EPS Next 3Y8.94%
EPS Next 5Y8.18%
Revenue 1Y (TTM)5.15%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%7.49%
Revenue Next Year5.1%
Revenue Next 2Y5.38%
Revenue Next 3Y5.89%
Revenue Next 5Y7.38%
EBIT growth 1Y19.77%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year57.21%
EBIT Next 3Y22.62%
EBIT Next 5Y14.77%
FCF growth 1Y31.74%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y29.99%
OCF growth 3Y1.77%
OCF growth 5Y15.28%